Literature DB >> 15019178

Amnesic shellfish poison.

B Jeffery1, T Barlow, K Moizer, S Paul, C Boyle.   

Abstract

Amnesic shellfish poisoning (ASP) is caused by consumption of shellfish that have accumulated domoic acid, a neurotoxin produced by some strains of phytoplankton. The neurotoxic properties of domoic acid result in neuronal degeneration and necrosis in specific regions of the hippocampus. A serious outbreak of ASP occurred in Canada in 1987 and involved 150 reported cases, 19 hospitalisations and 4 deaths after consumption of contaminated mussels. Symptoms ranged from gastrointestinal disturbances, to neurotoxic effects such as hallucinations, memory loss and coma. Monitoring programmes are in place in numerous countries worldwide and closures of shellfish harvesting areas occur when domoic acid concentrations exceed regulatory limits. This paper reviews the chemistry, sources, metabolism and toxicology of domoic acid as well as human case reports of ASP and discusses a possible mechanism of toxicity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15019178     DOI: 10.1016/j.fct.2003.11.010

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  30 in total

Review 1.  Domoic acid as a developmental neurotoxin.

Authors:  Lucio G Costa; Gennaro Giordano; Elaine M Faustman
Journal:  Neurotoxicology       Date:  2010-05-13       Impact factor: 4.294

2.  Ischemic cardiomyopathy following seizure induction by domoic Acid.

Authors:  Alexandra Vranyac-Tramoundanas; Joanne C Harrison; Punam M Sawant; D Steven Kerr; Ivan A Sammut
Journal:  Am J Pathol       Date:  2011-05-14       Impact factor: 4.307

3.  Preclinical modeling of exposure to a global marine bio-contaminant: Effects of in utero Domoic acid exposure on neonatal behavior and infant memory.

Authors:  Kimberly S Grant; Brenda Crouthamel; Caroline Kenney; Noelle McKain; Rebekah Petroff; Sara Shum; Jing Jing; Nina Isoherranen; Thomas M Burbacher
Journal:  Neurotoxicol Teratol       Date:  2019-01-25       Impact factor: 3.763

4.  Effects of oral domoic acid exposure on maternal reproduction and infant birth characteristics in a preclinical nonhuman primate model.

Authors:  Thomas M Burbacher; Kimberly S Grant; Rebekah Petroff; Sara Shum; Brenda Crouthamel; Courtney Stanley; Noelle McKain; Jing Jing; Nina Isoherranen
Journal:  Neurotoxicol Teratol       Date:  2019-01-05       Impact factor: 3.763

5.  Chronic, low-level oral exposure to marine toxin, domoic acid, alters whole brain morphometry in nonhuman primates.

Authors:  Rebekah Petroff; Todd Richards; Brenda Crouthamel; Noelle McKain; Courtney Stanley; Kimberly S Grant; Sara Shum; Jing Jing; Nina Isoherranen; Thomas M Burbacher
Journal:  Neurotoxicology       Date:  2019-02-28       Impact factor: 4.294

Review 6.  Ligands for ionotropic glutamate receptors.

Authors:  Geoffrey T Swanson; Ryuichi Sakai
Journal:  Prog Mol Subcell Biol       Date:  2009

7.  Novel symptomatology and changing epidemiology of domoic acid toxicosis in California sea lions (Zalophus californianus): an increasing risk to marine mammal health.

Authors:  T Goldstein; J A K Mazet; T S Zabka; G Langlois; K M Colegrove; M Silver; S Bargu; F Van Dolah; T Leighfield; P A Conrad; J Barakos; D C Williams; S Dennison; M Haulena; F M D Gulland
Journal:  Proc Biol Sci       Date:  2008-02-07       Impact factor: 5.349

8.  Muscarinic receptors prevent oxidative stress-mediated apoptosis induced by domoic acid in mouse cerebellar granule cells.

Authors:  Gennaro Giordano; Li Li; Collin C White; Fred M Farin; Hui W Wilkerson; Terrance J Kavanagh; L G Costa
Journal:  J Neurochem       Date:  2009-02-07       Impact factor: 5.372

Review 9.  Ageing and neuronal vulnerability.

Authors:  Mark P Mattson; Tim Magnus
Journal:  Nat Rev Neurosci       Date:  2006-04       Impact factor: 34.870

10.  Immunomodulatory effects of domoic acid differ between in vivo and in vitro exposure in mice.

Authors:  Milton Levin; Heather Leibrecht; James Ryan; Frances Van Dolah; Sylvain De Guise
Journal:  Mar Drugs       Date:  2008-12-22       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.